BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37880742)

  • 21. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
    Li H; Wang J; Li L; Zhao L; Wang Z
    World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M
    Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
    Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
    Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single-cell and bulk RNA-seq analysis.
    Han PZ; Tan LC; Ouyang QS; Yu PC; Shi X; Hu JQ; Wei WJ; Lu ZW; Wang Y; Ji QH; Qu N; Mai HM; Wang YL
    J Oral Pathol Med; 2023 May; 52(5):389-401. PubMed ID: 36153671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 28. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
    Li Q; Xiao X; Feng J; Yan R; Xi J
    Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer.
    Yang J; Li Y; Sun Z; Fan Z; Shi M; Liu S; Meng Y; Zhou B; Jiang Y; Zhan H
    Biochem Biophys Res Commun; 2022 Dec; 632():1-9. PubMed ID: 36191371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATA6 regulates expression of annexin A10 (ANXA10) associated with epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Takayama S; Morita Y; Nishimoto A; Nishimura J; Takebe K; Kishimoto S; Matsumiya-Matsumoto Y; Matsunaga K; Imai T; Uzawa N
    Arch Oral Biol; 2022 Dec; 144():105569. PubMed ID: 36265396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer.
    Weng Y; Qian H; Hong L; Zhao S; Deng X; Shen B
    Front Immunol; 2022; 13():1089008. PubMed ID: 36713450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.
    Brennan K; Espín-Pérez A; Chang S; Bedi N; Saumyaa S; Shin JH; Plevritis SK; Gevaert O; Sunwoo JB; Gentles AJ
    Genome Med; 2023 Nov; 15(1):98. PubMed ID: 37978395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8
    Zhuang H; Zhou Z; Zhang Z; Chen X; Ma Z; Huang S; Gong Y; Zhang C; Hou B
    Aging (Albany NY); 2020 Dec; 13(2):2310-2329. PubMed ID: 33316775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1.
    Zhang X; Luo Y; Cen Y; Qiu X; Li J; Jie M; Yang S; Qin S
    Cell Death Dis; 2022 Nov; 13(11):923. PubMed ID: 36333284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.